Patent · US Active

Delivery systems and kits for gene editing

US10047355B2 · kind B2 · utility

14Cited by
12References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 9, 2016
Grant dateAug 14, 2018
Priority date
Expiry dateDec 9, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to compositions and methods for modifying a gene sequence, and for systems for delivering such compositions. For example, the disclosure relates to modifying a gene sequence using a CRISPR-Cas9 or other nucleic acid editing system, and methods and delivery systems for achieving such gene modification, such as viral or non-viral delivery systems.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.